U.S. names HIV, arthritis drugs for next Medicare price talks

U.S. names HIV, arthritis drugs for next Medicare price talks

Eli Lilly’s office in San Diego, Nov. 21, 2025. Mike Blake | Reuters The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences’ HIV drug Biktarvy and Pfizer’s arthritis treatment Xeljanz. It is the third round of drugs subject to former President Joe Biden’s Inflation Reduction Act of 2022, which allowed the government to negotiate prices of…

Read More
ASML Q4 2025 earnings report

ASML Q4 2025 earnings report

onathan Raa | Nurphoto | Getty Images ASML reported orders that smashed past expectations while 2026 sales guidance was also ahead of estimates as AI demand continues to support the Dutch chip giant’s business. Bookings, one of the most closely-watched metrics from investors, came in at 13.2 billion euros ($15.8 billion) in the fourth quarter…

Read More